Does environmental investment pay off?—portfolio analyses of the E in ESG during political conflicts and public health crises
Journal of Financial Research · 2023-12 · 46 (S1)
DOI: 10.1111/jfir.12357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Financial Research, online erschienen am 05.11.2023. Verfasst von Jiancheng Shen und 2 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
This paper examines the contribution of environmental investment on firm value during the Russia‐Ukraine War and Global Public Health Crisis. Using media‐based environmental scores, we investigate the performance of the emission‐reduction‐based and green‐innovation‐based portfolios. The results indicate that while engaging in environmental activities decreases firm value during the noncrisis time, it creates value when companies face market‐wide crises. Our findings suggest that environmental investment serves as a risk‐hedging vehicle for political and health crises. In addition, compared to corporate ESG disclosures, firm‐level media‐based environmental scores mitigate the endogeneity between a company's ESG disclosure policies and its firm characteristics.
Zitieren
APA
Shen, J., Chen, C., & Liu, Z. (2023). Does environmental investment pay off?—portfolio analyses of the E in ESG during political conflicts and public health crises. Journal of Financial Research, 46(S1). https://doi.org/10.1111/jfir.12357
Vancouver
Shen J, Chen C, Liu Z. Does environmental investment pay off?—portfolio analyses of the E in ESG during political conflicts and public health crises. Journal of Financial Research. 2023;46(S1). doi:10.1111/jfir.12357
BibTeX
@article{Shen2023,
author = {Shen, Jiancheng and Chen, Chen and Liu, Zheng},
title = {Does environmental investment pay off?—portfolio analyses of the E in ESG during political conflicts and public health crises},
journal = {Journal of Financial Research},
year = {2023},
volume = {46},
number = {S1},
doi = {10.1111/jfir.12357}
}
EUVIMED